REGISTERED
on 04 Oct 2022
Last Applicant/ Owned by
1551 Eastlake Avenue E, Suite 200
Seattle
WA
98102
Serial Number
87878532 filed on 16th Apr 2018
Registration Number
6866517 registered on 04th Oct 2022
Correspondent Address
Hoang-chi Truong
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
ADAPTIVE
Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly Providing medical diagnostic assays and diagnostic and Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy
First Use Date in General
08th Sep 2009
First Use Date in Commerce
08th Sep 2009
Class [044]
Medical, Beauty & Agricultural Services
Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly
First Use Date in General
16th Feb 2012
First Use Date in Commerce
16th Feb 2012
Mark Details
Serial Number
No 87878532
Mark Type
No Service Mark
Attorney Docket Number
No 10214-00502-
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 04th Oct 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 04th Oct 2022 | REGISTERED-PRINCIPAL REGISTER |
| 30th Aug 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 29th Aug 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 06th Aug 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 05th Aug 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 05th Aug 2022 | SOU EXTENSION 1 GRANTED |
| 01st Aug 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 15th Jul 2022 | SOU EXTENSION 1 FILED |
| 15th Jul 2022 | USE AMENDMENT FILED |